A Novel Conditioning Regimen for Myelodysplastic Syndrome With Moderate High IPSS-M Score

计划入组 40 人 · 首次发布于 2024 年 2 月 28 日

Prophylactic Intervention for Relapse Prevention Post-Allogeneic Transplantation in Very High-Risk MDS Patients Based on IPSS-M Stratification

计划入组 40 人 · 首次发布于 2024 年 9 月 25 日

Pacritinib With Aza for Upfront Myelodysplastic Syndrome

计划入组 25 人 · 首次发布于 2026 年 2 月 4 日

M-5291

M-121101

M-300

BATEMAN, TIMOTHY M. M. MD

United States

COSTELLO, JOHN M.

United States

Florida A&M University

United States

IPSS-M Identifies Hidden High-Risk Biology in Clinically Lower-Risk MDS, Guiding Earlier Transplant Decisions

Advancements in Higher-Risk MDS Treatment Strategies Explored

Tapotoclax Shows Limited Efficacy in Myelodysplastic Syndromes After HMA Failure